VatanicVatanic

CONTACTCONTACT

iPS細胞を動物再生医療の真ん中にまずは犬から。

TECHNOLOGY

多様な疾患治療が可能に

Various regenerative medicine
expands from iPS Cells

iPS cells are pluripotent stem cells capable of differentiating into various cell types. We establish standardized animal iPS cells as the starting material (master cells) and provide therapeutic technologies in various disease fields from these cells to save as many lives as possible.

First, we will induce the differentiation of canine mesenchymal stem cells (MSCs) from canine iPS cells to prove their efficacy in the treatment of various diseases such as systemic inflammatory diseases, autoimmune diseases, spinal cord injuries etc., then proceed with development in order to obtain manufacturing and marketing approval as "regenerative medicine products for veterinary use" from the Ministry of Agriculture, Forestry and Fisheries.

Canine iPS Cell Patent (PCT/JP2020/016924)Joint application by Keio University&Nihon University
  • Canine iPS Cell Patent (PCT/JP2020/016924)Joint application by Keio University&Nihon University
  • Canine iPS Cell Patent (PCT/JP2020/016924)Joint application by Keio University&Nihon University
  • Canine iPS Cell Patent (PCT/JP2020/016924)Joint application by Keio University&Nihon University

Canine iPS Cell Patent(PCT/JP2020/016924)Joint application
by Keio University
&Nihon University

Technical problems are successfully solved.
 ‘Clinical Grade’ iPS cells is now ready.

Unlike humans and mice, some animal species such as dogs have had difficulty establishing iPS cells without residual reprogramming factors. Professor Okano from Keio University and our technical founders Dr. Shiozawa and Dr. Edamura first tried out various combinations of medium conditions (e.g. addition of growth factors and small molecule compounds) and reprogramming factor gene sets using common marmoset skin and discovered a new method for establishing iPS cells which are induced into iPS cells via intermediate cells with properties similar to neural stem cells. A new iPS cell establishment method was discovered and the same effect was subsequently observed in other animal species that are known to resist pluripotency induction. The iPS cells established by this method have the ability to differentiate into trichodermal cells and primordial germ cell-like cells and the reprogramming factors have been completely eliminated making them a suitable stem cell resource for clinical applications.

Conventional

Compared to humans, mice, etc.,canine somatic cell Induction canine iPS CellInduction was difficult

  • Induction is inadequate with the same reprogramming factors as in humans.
  • Viral vectors are pathogenic in animals
  • Xenogenic animal components elicit an immune response.

Vetanic canine iPS cells

Inducing iPS cells with highly efficient
and high quality
while applying them safely to clinical practice.

  • Submitted papers
  • ・Non-viral Induction of Transgene-free iPSCs from Somatic Fibroblasts of Multiple Mammalian Species. Stem Cell Reports 16 (2021) 1–17
  • ・Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog. Stem Cell Research 53 (2021) 102375
Vatanic

Successful construction of canine iPS cells holds the potential to revolutionise current treatment methods.

Identification of a novel set of reprogramming factors capable of maintaining pluripotency over the long term; introduction of genes into cells without the use of viruses; and successful construction of ‘animal iPS cells suitable for clinical applications’ with high efficiency and excellent proliferative potential are the potentials to imitate the development of animal regenerative medicine product that can revolutionize current treatment methods

現在の治療方法を一新する可能性のあるイヌiPS細胞の構築に成功。

Reference
Keio Univ. Press Release “Establishment of method to induce iPS cells from various animal species” (Japanese PR only)
Non-viral Induction of Transgene-free iPSCs from Somatic Fibroblasts of Multiple Mammalian Species.  Stem Cell Reports 16 (2021) 1–17
Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog.  Stem Cell Research 53 (2021) 102375

We are expanding our technology not only to dogs,
But also to cats, horses,
and other animal species soon.

現状の動物再生医療 今後の動物再生医療

Our patented technology has made it possible to establish canine iPS cells. We are currently working on the practical application of regenerative medicine products starting with canine iPS cells; but of course, we are not limited to dog only. Currently, cats are accounted for more than half of all companion animals. We aim to begin research on feline iPS cells as soon as possible to bring ease of concern and joy to their families. Moreover, horses also have close relationships with people as part of irreplaceable family members in other countries. We believe that the importance of regenerative medicine is even higher for these animals as their bodies is much larger compared to those of dogs and cats. We will advance the research and development so that regenerative medicine for horses can be put to practice use as soon as possible.